The implantable brain–computer interface (BCI) hand motor function compensation system NEO, developed by Borui Kang Medical Technology (Shanghai) Co., Ltd., received market approval from Shanghai regulators and underwent its first commercial clinical surgery on July 13 at Huashan Hospital affiliated with Fudan University. Intraoperative testing showed the system recorded stable, high-quality epidural EEG signals. The patient is reported hemodynamically stable post‑op. Authorities describe NEO as

The implantable brain–computer interface (BCI) hand motor function compensation system NEO, developed by Borui Kang Medical Technology (Shanghai) Co., Ltd., received market approval from Shanghai regulators and underwent its first commercial clinical surgery on July 13 at Huashan Hospital affiliated with Fudan University. Intraoperative testing showed the system recorded stable, high-quality epidural EEG signals. The patient is reported hemodynamically stable post‑op. Authorities describe NEO as a world‑first product.